Avio Smart Market Stack explores diagnostics collaboration with Mediciti

Avio Smart Market Stack Limited has initiated discussions with Mediciti Institute of Medical Sciences to explore research collaboration and clinical validation opportunities. The interaction featured Huwel Lifesciences' indigenous molecular diagnostic technologies aimed at improving disease detection and healthcare outcomes.

Hyderabad: As part of its strategy to build a scalable diagnostics and healthcare business, Avio Smart Market Stack Limited (formerly Bartronics India Limited) initiated strategic discussions with Mediciti Institute of Medical Sciences (MIMS), Hyderabad, to explore opportunities for research collaboration, clinical validation and the adoption of advanced molecular diagnostic technologies. As part of the interaction, Huwel Lifesciences, ASMS’ strategic molecular diagnostics partner, showcased its portfolio of indigenous diagnostic technologies and ongoing innovations in molecular diagnostics.

The discussions brought together leadership teams, clinicians, researchers and academic experts to examine how innovative molecular diagnostic solutions can strengthen disease detection, improve clinical decision-making and enhance healthcare outcomes across India.

---

During the discussions, Huwel Lifesciences showcased its comprehensive portfolio of indigenous molecular diagnostic technologies, including solutions for tuberculosis, multidrug-resistant tuberculosis (MDR-TB), sepsis, HPV screening, hepatitis, antimicrobial resistance (AMR) detection, respiratory diseases and environmental surveillance.

The company highlighted its fully integrated diagnostics platform spanning assay development, reagent manufacturing, instrumentation, software and data management, designed to deliver scalable and affordable diagnostic solutions for healthcare providers.

Vidyasagar Reddy, Managing Director, Avio Smart Market Stack, said, “ASMS has made a significant commitment to building a scalable diagnostics and healthcare business through its strategic partnership with Huwel Lifesciences.”

Dr Shesheer Kumar, Founder and Director, Huwel Lifesciences, said, “Mediciti’s strong research capabilities and clinical expertise make it an ideal partner for advancing scientific validation and evaluating the impact of innovative diagnostics in real-world healthcare settings.”